Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) EBITDA Margin (2016 - 2025)

Ultralife (ULBI) has 15 years of EBITDA Margin data on record, last reported at 3.36% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 636.0% year-over-year to 3.36%; the TTM value through Sep 2025 reached 0.93%, down 517.0%, while the annual FY2024 figure was 3.63%, 97.0% down from the prior year.
  • EBITDA Margin reached 3.36% in Q3 2025 per ULBI's latest filing, down from 3.61% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 7.61% in Q4 2023 and bottomed at 3.36% in Q3 2025.
  • Average EBITDA Margin over 4 years is 3.24%, with a median of 3.3% recorded in 2025.
  • The widest YoY moves for EBITDA Margin: up 681bps in 2024, down -927bps in 2024.
  • A 4-year view of EBITDA Margin shows it stood at 2.98% in 2021, then soared by 155bps to 7.61% in 2023, then tumbled by -122bps to 1.66% in 2024, then crashed by -102bps to 3.36% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 3.36% in Q3 2025, 3.61% in Q2 2025, and 4.29% in Q1 2025.